Cargando…

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis

Detalles Bibliográficos
Autores principales:	Li, B, Zhang, P, Feng, G, Xu, Z, Qin, T, Zhang, Y, Sha, Z, Dong, D, Zhang, H, Fang, L, Pan, L, Hu, N, Qu, S, Cai, W, Huang, G, Xiao, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223151/ https://www.ncbi.nlm.nih.gov/pubmed/27935577 http://dx.doi.org/10.1038/bcj.2016.116

Ejemplares similares

PB1937: UTILITY OF STERNAL BONE MARROW CELL MORPHOLOGY EVALUATION FOR DIAGNOSTIC CATEGORIZATION IN PATIENTS WITH ACQUIRED HYPOCELLULAR BONE MARROW FAILURE SYNDROMES
por: Chen, J., et al.
Publicado: (2022)

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
por: Dunbar, Andrew J., et al.
Publicado: (2023)

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA
por: Xu, Z., et al.
Publicado: (2022)

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
por: Jamieson, Catriona, et al.
Publicado: (2015)

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly
por: Sollazzo, Daria, et al.
Publicado: (2016)

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
por: Kvasnicka, Hans Michael, et al.
Publicado: (2018)

Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
por: Dello Spedale Venti, Michele, et al.
Publicado: (2022)

P999: ERK1/2 INHIBITION REDUCES OSTEOPONTIN PLASMA LEVELS AND BONE MARROW FIBROSIS IN A MYELOFIBROSIS MOUSE MODEL
por: Rontauroli, S., et al.
Publicado: (2022)

TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
por: Varricchio, Lilian, et al.
Publicado: (2021)

S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
por: Gleitz, Hélène, et al.
Publicado: (2023)

Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
por: Desterke, Christophe, et al.
Publicado: (2015)

Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Primary myelofibrosis evolving to an aplastic appearing marrow
por: Schaefer, Jordan K., et al.
Publicado: (2018)

Leptin receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis
por: Decker, Matthew, et al.
Publicado: (2017)

Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
por: Mesa, Ruben, et al.
Publicado: (2022)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update
por: Jain, Akriti G., et al.
Publicado: (2022)

Significance of bone marrow fibrosis in acute myeloid leukemia for survival in the real-world
por: Zhang, Xia, et al.
Publicado: (2022)

Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
por: Ozono, Yoshinori, et al.
Publicado: (2020)

Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model
por: Bianchi, Elisa, et al.
Publicado: (2023)

Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis
por: Martinaud, Christophe, et al.
Publicado: (2015)

Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
por: Leimkühler, Nils B., et al.
Publicado: (2021)

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
por: Massy, E, et al.
Publicado: (2021)

Trends in overall mortality among US veterans with primary myelofibrosis
por: Tashi, Tsewang, et al.
Publicado: (2023)

Repeatability of Quantitative Magnetic Resonance Imaging Biomarkers in the Tibia Bone Marrow of a Murine Myelofibrosis Model
por: Ross, Brian D., et al.
Publicado: (2023)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
por: Zingariello, Maria, et al.
Publicado: (2020)

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021)

Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
por: Sochacki, Andrew L., et al.
Publicado: (2022)

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients
por: Caramazza, D, et al.
Publicado: (2011)

A Pilot Study of Quantitative MRI Parametric Response Mapping of Bone Marrow Fat for Treatment Assessment in Myelofibrosis
por: Luker, Gary D., et al.
Publicado: (2016)

High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer
por: Qin, Lianzhi, et al.
Publicado: (2017)

Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients
por: Ruberti, S, et al.
Publicado: (2018)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
por: Perolla, A., et al.
Publicado: (2022)

Primary myelofibrosis marrow-derived CD14(+)/CD34(-) monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes
por: Manshouri, Taghi, et al.
Publicado: (2019)

PB2048: EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: A RETROSPECTIVE MULTICENTER STUDY
por: Chen, C., et al.
Publicado: (2022)

Non‐tumour bone marrow lymphocytes correlate with improved overall survival in childhood acute lymphoblastic leukaemia
por: Edwin, Claire, et al.
Publicado: (2016)

Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion
por: Li, X, et al.
Publicado: (2015)

APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
por: Chen, Jiajin, et al.
Publicado: (2022)

Survivin expression as an independent predictor of overall survival in malignant peritoneal mesothelioma
por: Zhang, Guozun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qht4bkk90dn19d898iot8egsig